Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Mehta

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|August 30, 2002
Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndromeBridget T Heelan, Vincent Tormey, Peter Amlot, et al.
Journal of Inherited Metabolic Disease|October 18, 2017
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort studyMaarten Arends, Simon Körver, Derralynn A Hughes, et al.
JAMA Neurology|December 16, 2014
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohortMichelle Beavan, Alisdair McNeill, Christos Proukakis, et al.
Neurology|March 13, 2015
Clinical prodromes of neurodegeneration in Anderson-Fabry diseaseMatthias Löhle, Derralynn Hughes, Alan Milligan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 11, 2003
Primary adenocarcinoma in a donor lung: evaluation and surgical managementErik A K Beyer, Malcolm M DeCamp, Nicholas G Smedira, et al.
British Journal of Haematology|December 17, 2003
Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromesAndres Virchis, Mickey Koh, Peter Rankin, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
Molecular Genetics and Metabolism|August 15, 2008
Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase betaAtul Mehta, Michael Beck, Christoph Kampmann, et al.
European Journal of Human Genetics : EJHG|March 1, 2007
Three-dimensional face shape in Fabry diseaseJosanne Cox-Brinkman, Anouk Vedder, Carla Hollak, et al.
European Heart Journal|May 8, 2007
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome surveyAles Linhart, Christoph Kampmann, José L Zamorano, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|August 30, 2002
Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndromeBridget T Heelan, Vincent Tormey, Peter Amlot, et al.
Journal of Inherited Metabolic Disease|October 18, 2017
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort studyMaarten Arends, Simon Körver, Derralynn A Hughes, et al.
JAMA Neurology|December 16, 2014
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohortMichelle Beavan, Alisdair McNeill, Christos Proukakis, et al.
Neurology|March 13, 2015
Clinical prodromes of neurodegeneration in Anderson-Fabry diseaseMatthias Löhle, Derralynn Hughes, Alan Milligan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 11, 2003
Primary adenocarcinoma in a donor lung: evaluation and surgical managementErik A K Beyer, Malcolm M DeCamp, Nicholas G Smedira, et al.
British Journal of Haematology|December 17, 2003
Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromesAndres Virchis, Mickey Koh, Peter Rankin, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
Molecular Genetics and Metabolism|August 15, 2008
Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase betaAtul Mehta, Michael Beck, Christoph Kampmann, et al.
European Journal of Human Genetics : EJHG|March 1, 2007
Three-dimensional face shape in Fabry diseaseJosanne Cox-Brinkman, Anouk Vedder, Carla Hollak, et al.
European Heart Journal|May 8, 2007
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome surveyAles Linhart, Christoph Kampmann, José L Zamorano, et al.
Pageof 15